CA2345000A1 - Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux - Google Patents

Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux Download PDF

Info

Publication number
CA2345000A1
CA2345000A1 CA002345000A CA2345000A CA2345000A1 CA 2345000 A1 CA2345000 A1 CA 2345000A1 CA 002345000 A CA002345000 A CA 002345000A CA 2345000 A CA2345000 A CA 2345000A CA 2345000 A1 CA2345000 A1 CA 2345000A1
Authority
CA
Canada
Prior art keywords
levels
cancer
patient
cells
tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002345000A
Other languages
English (en)
Inventor
Roberto A. Macina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2345000A1 publication Critical patent/CA2345000A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne un nouveau procédé pour détecter, diagnostiquer, surveiller, établir la stadification, faire des prévisions, obtenir des images et procéder à un traitement en rapport avec des cancers gastro-intestinaux, y compris ceux de l'intestin grêle, du côlon et de l'estomac.
CA002345000A 1998-10-02 1999-09-30 Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux Abandoned CA2345000A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10287998P 1998-10-02 1998-10-02
US60/102,879 1998-10-02
PCT/US1999/022725 WO2000020640A1 (fr) 1998-10-02 1999-09-30 Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux

Publications (1)

Publication Number Publication Date
CA2345000A1 true CA2345000A1 (fr) 2000-04-13

Family

ID=22292156

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002345000A Abandoned CA2345000A1 (fr) 1998-10-02 1999-09-30 Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux

Country Status (4)

Country Link
EP (1) EP1117833A4 (fr)
JP (1) JP2002526760A (fr)
CA (1) CA2345000A1 (fr)
WO (1) WO2000020640A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767704B2 (en) 2000-03-27 2004-07-27 Thomas Jefferson University Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression
US6962779B1 (en) 1998-10-02 2005-11-08 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
WO2002000939A2 (fr) * 2000-06-28 2002-01-03 Diadexus, Inc. Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon
EP1241269A3 (fr) * 2001-03-16 2004-05-19 Ortho-Clinical Diagnostics, Inc. Procédé de détection de la protéine de type REG et molécules d'acides nucléiques codant pour cette protéine
US7560531B2 (en) 2003-05-29 2009-07-14 Diadexus, Inc. Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
US20060134653A1 (en) * 2004-07-28 2006-06-22 Bayer Healthcare Llc Differential expression of genes in microsatellite instability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861494A (en) * 1995-06-06 1999-01-19 Human Genome Sciences, Inc. Colon specific gene and protein
ATE313647T1 (de) * 1995-06-06 2006-01-15 Human Genome Sciences Inc Dickdarm spezifische gene und proteine
CA2265923A1 (fr) * 1996-09-13 1998-03-19 Sagami Chemical Research Center Proteines humaines comportant des sequences de signaux secretoires et adn codant ces proteines
US5837841A (en) * 1996-10-11 1998-11-17 Incyte Pharmaceuticals, Inc. Human Reg protein

Also Published As

Publication number Publication date
JP2002526760A (ja) 2002-08-20
EP1117833A4 (fr) 2002-08-14
EP1117833A1 (fr) 2001-07-25
WO2000020640A1 (fr) 2000-04-13

Similar Documents

Publication Publication Date Title
EP1109937B1 (fr) PROCEDE DE DIAGNOSTIC, DE SURVEILLANCE, DE CLASSIFICATION PAR STADES et D'IMAGERIE DE DIVERS CANCERS
US7858325B2 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6902892B1 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
CA2347906A1 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
US20050266483A1 (en) Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1131095A1 (fr) Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
CA2347656A1 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
CA2345000A1 (fr) Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux
US6962779B1 (en) Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
EP1126877A1 (fr) Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate
US7014996B1 (en) Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
CA2345285A1 (fr) Nouveau procede pour diagnostiquer, controler, etablir le bilan d'extension, visualiser, et traiter des cancers gynecologiques
US6869592B1 (en) Method and antibody for imaging lung cancer
CA2346326A1 (fr) Nouveau procede de diagnostic, de controle, de stadification, d'imagerie et de traitement de cancers gynecologiques ou de cancers de la prostate
US20050106620A1 (en) Novel method of diagnosing, monitoring, staging, imaging and treating cancer
WO2000012761A1 (fr) Nouvel anticorps permettant de diagnostiquer le cancer de la vessie

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued